This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wood, W. M. Articles by Ridgway, E. C. Search for Related Content PubMed PubMed Citation Articles by Wood, W. M. Articles by Ridgway, E. C. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Thyroid Cancer

Early Gene Expression Changes Preceding Thyroid Hormone-Induced Involution of a Thyrotrope Tumor

Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262

Address all correspondence and requests for reprints to: William M. Wood, Ph.D., Department of Medicine University of Colorado Health Sciences Center (B-151), 4200 East Ninth Avenue, Box B151, Denver, Colorado 80262. E-mail: William.Wood{at}uchsc.edu

Treatment with thyroid hormone (TH) results in shrinkage of a thyrotropic tumor grown in a hypothyroid host. We used microarray and Northern analysis to assess the changes in gene expression that preceded tumor involution. Of the 1,176 genes on the microarray, 7 were up-regulated, whereas 40 were decreased by TH. Many of these were neuroendocrine in nature and related to growth or apoptosis. When we examined transcripts for cell cycle regulators only cyclin-dependent kinase 2, cyclin A and p57 were down-regulated, whereas p15 was induced by TH. Retinoblastoma protein, c-myc, and mdm2 were unchanged, but E2F1 was down-regulated. TH also decreased expression of brain-derived neurotrophic factor, its receptor trkB, and the receptor for TRH. These, in addition to two other genes, neuronatin and PB cadherin, which were up- and down-regulated, respectively, showed a more rapid response to TH than the cell cycle regulators and may represent direct targets of TH. Finally, p19ARF was dramatically induced by TH, and although this protein can stabilize p53 by sequestering mdm2, we found no increase in p53 protein up to 48 h of treatment. In summary, we have described early changes in the expression of genes that may play a role in TH-induced growth arrest of a thyrotropic tumor. These include repression of specific growth factor and receptors and cell cycle genes as well as induction of other factors associated with growth arrest and apoptosis.

This article has been cited by other articles:

				I. H. Chan and M. L. Privalsky Isoform-Specific Transcriptional Activity of Overlapping Target Genes that Respond to Thyroid Hormone Receptors {alpha}1 and {beta}1 Mol. Endocrinol., November 1, 2009; 23(11): 1758 - 1775. [Abstract] [Full Text] [PDF]

				K Revill, K J Dudley, R N Clayton, A M McNicol, and W E Farrell Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma Endocr. Relat. Cancer, June 1, 2009; 16(2): 537 - 548. [Abstract] [Full Text] [PDF]

				C. Lu, M. C. Willingham, F. Furuya, and S.-y. Cheng Activation of Phosphatidylinositol 3-Kinase Signaling Promotes Aberrant Pituitary Growth in a Mouse Model of Thyroid-Stimulating Hormone-Secreting Pituitary Tumors Endocrinology, July 1, 2008; 149(7): 3339 - 3345. [Abstract] [Full Text] [PDF]

				M. C. Zatelli, M. R. Ambrosio, M. Bondanelli, and E. C d. Uberti Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds Eur. J. Endocrinol., April 1, 2007; 156(suppl_1): S29 - S35. [Abstract] [Full Text] [PDF]

				W E Farrell Pituitary tumours: findings from whole genome analyses. Endocr. Relat. Cancer, September 1, 2006; 13(3): 707 - 716. [Abstract] [Full Text] [PDF]

				W. W. Woodmansee, J. M. Kerr, E. A. Tucker, J. R. Mitchell, D. J. Haakinson, D. F. Gordon, E. C. Ridgway, and W. M. Wood The Proliferative Status of Thyrotropes Is Dependent on Modulation of Specific Cell Cycle Regulators by Thyroid Hormone Endocrinology, January 1, 2006; 147(1): 272 - 282. [Abstract] [Full Text] [PDF]

				D. G Morris, M. Musat, S. Czirjak, Z. Hanzely, D. M Lillington, M. Korbonits, and A. B Grossman Differential gene expression in pituitary adenomas by oligonucleotide array analysis Eur. J. Endocrinol., July 1, 2005; 153(1): 143 - 151. [Abstract] [Full Text] [PDF]

				C. C. Helbing, K. Werry, D. Crump, D. Domanski, N. Veldhoen, and C. M. Bailey Expression Profiles of Novel Thyroid Hormone-Responsive Genes and Proteins in the Tail of Xenopus laevis Tadpoles Undergoing Precocious Metamorphosis Mol. Endocrinol., July 1, 2003; 17(7): 1395 - 1409. [Abstract] [Full Text] [PDF]

				M. Yamashita, E. Glasgow, B.-J. Zhang, K. Kusano, and H. Gainer Identification of Cell-Specific Messenger Ribonucleic Acids in Oxytocinergic and Vasopressinergic Magnocellular Neurons in Rat Supraoptic Nucleus by Single-Cell Differential Hybridization Endocrinology, November 1, 2002; 143(11): 4464 - 4476. [Abstract] [Full Text] [PDF]

				D. Soulet and S. Rivest Perspective: How to Make Microarray, Serial Analysis of Gene Expression, and Proteomic Relevant to Day-to-Day Endocrine Problems and Physiological Systems Endocrinology, June 1, 2002; 143(6): 1995 - 2001. [Abstract] [Full Text] [PDF]

				A. Spada and P. Beck-Peccoz Editorial: New Strategy to Solve the Etiopathogenetic Conundrum of Pituitary Adenomas Endocrinology, February 1, 2002; 143(2): 343 - 346. [Full Text] [PDF]